Hos hypertensive diabetespatienter med kronisk nyreinsufficiens og åbenlys proteinuri forekom hyperkaliæmi (≥ 5, 5 mEq/ l) hos 46, 3% (dvs. meget almindelig) af patienterne i irbesartan- gruppen og 26, 3% af patienterne i placebo- gruppen.
In diabetic hypertensive patients with chronic renal insufficiency and overt proteinuria, hyperkalaemia (≥ 5.5 mEq/ L) occurred in 46.3% (i. e. very common) of the patients in the irbesartan group and 26.3% of the patients in the placebo group.